(Q40109882)

17 September 2017

Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes (English)

1 reference

17 September 2017

Jau-Ling Suen

2

0 references

author name string

Chih-Hsing Hung

1

1 reference

17 September 2017

Yi-Ming Hua

3

1 reference

17 September 2017

Wen Chiang

4

1 reference

17 September 2017

Hui-Chiu Chang

5

1 reference

17 September 2017

Chun-Nan Chen

6

1 reference

17 September 2017

Yuh-Jyh Jong

7

1 reference

17 September 2017

1 August 2007

1 reference

Pediatric Allergy & Immunology

17 September 2017

1 reference

17 September 2017

18

1 reference

17 September 2017

5

1 reference

17 September 2017

378-384

1 reference

Cytokines and chemoattractants in allergic inflammation

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Endotoxin-stimulated innate immunity: A contributing factor for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Endotoxin exposure in allergy and asthma: reconciling a paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Inhibitory effects of ketotifen on eotaxin‐dependent activation of eosinophils: consequences for allergic eye diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Churg-Strauss vasculitis syndrome and leukotriene receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2007.00535.X

10.1111/J.1399-3038.2007.00535.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference